The global steerable needles market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 6.38% from 2023 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing demand for technologically advanced steerable needles among different healthcare settings to perform robotic surgery. According to the National Center for Biotechnology Information (NCBI), around 876,000 robotic-assisted surgery (RAS) procedures were performed in 2020. Thus, an increasing number of robotic-assisted surgery (RAS) cases are anticipated to boost demand for steerable needles during the forecast period.
Significant technological advancements have been made in the development of steerable needles in recent years. These advancements have led to the development of more precise and accurate steerable needles and steerable needles that are compatible with a wide range of imaging modalities. For instance, in October 2022, Strasbourg University's Lennart Rubbert and EPFL's Charles Baur developed a needle with a steerable tip known as the ARC needle. Currently, this ARC needle technology is being commercialized by the French Company Conectus. Thus, the successful completion of clinical trials and subsequent approval of products is projected to fuel the market growth over the forecast period.
Moreover, several global market players are undertaking various initiatives such as joint ventures to strengthen their market positions. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in April 2023, Serpex Medical and Body Vision Medical jointly announced the completion of the first lung nodule biopsy using Sepex’s compass steerable needle navigated by Body Vision’s LungVision real-time, intraoperative CT imaging system carried out by Dr. Michael Machuzak at Cleveland Clinic. This initiative will strengthen the adoption of newly launched steerable needles worldwide, thereby driving the market growth.
Request a free sample copy or view report summary: Steerable Needles Market Report
In 2022, the bevel-tip flexible needle dominated the type segment, owing to its growing usage in different healthcare settings such as hospitals, dental clinics, and others
In 2022, the biopsy segment dominated the application segment, owing to the increased awareness about the importance of steerable needles over traditional needles in medical surgical centers to perform safe and effective biopsies
In 2022, the hospitals segment dominated the end-use segment, due to the increased number of hospital admissions related to chronic diseases such as cancer, cardiovascular disease, and neurological disease
The North America region held the largest share of the market in 2022, owing to the technological advancements and high investment by the government to support the adoption of advanced steerable needles
Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas
Grand View Research has segmented the global steerable needles market based on type, application, end-use, and region:
Steerable Needles Type Outlook (Revenue, USD Million, 2018 - 2030)
Bevel-tip Flexible Needle
Symmetric-tip Needle
Tendonactuated Tips
Steerable Needles Application Outlook (Revenue, USD Million, 2018 - 2030)
Biopsy
Tumor Ablation
Pain Management
Robotic Assisted Surgery
Others
Steerable Needles End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
Steerable Needles Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Steerable Needles Market
AprioMed, Inc.
Merit Medical Systems.
DEAM
Johnson & Johnson Services, Inc.
Boston Scientific Corporation
Serpex Medical
Olympus Corporation
Medtronic
APT Medical Inc.
"The quality of research they have done for us has been excellent..."